
Vericel Corporation VCEL
$ 36.53
-0.04%
Quarterly report 2025-Q3
added 11-06-2025
Vericel Corporation EV/EBITDA Ratio 2011-2025 | VCEL
Annual EV/EBITDA Ratio Vericel Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -336 | 392 | -75.2 | -266 | -17.6 | -3.13 | -2.36 | -0.278 | -0.128 | -1.24 | -2.54 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 392 | -336 | -28.5 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
-3.41 | $ 4.89 | 3.82 % | $ 812 M | ||
|
Aclaris Therapeutics
ACRS
|
-9.24 | $ 3.22 | -1.08 % | $ 249 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Aptevo Therapeutics
APVO
|
-2.13 | $ 1.07 | -5.31 % | $ 295 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
-15.7 | $ 213.6 | -3.09 % | $ 5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.1 | -5.53 % | $ 7.46 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
BioVie
BIVI
|
-0.244 | $ 1.43 | -1.72 % | $ 2.11 M | ||
|
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-12.7 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
4.1 | $ 93.97 | -0.89 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
17.3 | $ 26.35 | 4.25 % | $ 1.28 B | ||
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | ||
|
Anika Therapeutics
ANIK
|
38.7 | $ 9.62 | 0.63 % | $ 141 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 0.26 | -8.44 % | $ 566 M | ||
|
Catalyst Biosciences
CBIO
|
0.34 | $ 13.28 | -5.78 % | $ 874 M | ||
|
Arena Pharmaceuticals
ARNA
|
-9.01 | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
0.437 | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | ||
|
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
0.957 | - | 1083.1 % | $ 745 M | ||
|
Axon Enterprise
AXON
|
-63.9 | $ 550.6 | -2.43 % | $ 41.7 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-1.92 | $ 2.37 | 3.04 % | $ 14.9 M | ||
|
AstraZeneca PLC
AZN
|
76.5 | $ 91.34 | 1.68 % | $ 96.9 B | ||
|
Celldex Therapeutics
CLDX
|
0.185 | $ 27.0 | -1.85 % | $ 1.74 M | ||
|
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
0.668 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
-208 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-14.9 | $ 11.3 | -2.04 % | $ 731 M | ||
|
Biogen
BIIB
|
12.7 | $ 175.09 | 0.57 % | $ 25.5 B | ||
|
Abeona Therapeutics
ABEO
|
0.0546 | $ 5.07 | -5.5 % | $ 108 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
17.3 | $ 87.9 | -0.1 % | $ 9.07 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
7.16 | $ 24.31 | 2.92 % | $ 2.88 B | ||
|
ADiTx Therapeutics
ADTX
|
0.0334 | $ 1.6 | -28.57 % | $ 21.1 K | ||
|
Cellectar Biosciences
CLRB
|
1.31 | $ 3.33 | -8.01 % | $ 40.7 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
1.13 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
-16.9 | - | -7.31 % | $ 87 M | ||
|
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M |